Health Canada approves Vertex's Trikafta for cystic fibrosis in children

Health Canada issued marketing authorisation to Vertex Pharmaceuticals' Trikafta for children with cystic fibrosis aged six to 11 years.

Related Keywords

Canada ,Canadians ,Canadian ,Reshma Kewalramani ,Vertex Pharmaceuticals ,Canadian Agency For Drugs ,Health Technology Assessments ,European Commission ,Health Canada ,Technologies In Health ,Vertex Pharmaceuticals Incorporated ,Canadian Agency ,Health Technology ,Vertex Pharmaceutical Kaftrio ,Measurement Instruments ,Chain Refrigerated ,Process Technologies ,